Cerevel Therapeutics Holdings, Inc.

Report date
6/30/2024
Quarter
2024 Q2
Filed
8/12/2024
Shares
65,679,781
Value ($000)
2,685,646
Weight
57.0%
2020 Q4 - 2024 Q2 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).